The litigation alleges that GPGI issued materially false and misleading statements throughout the class period regarding its acquisition of Husky. According to the complaint, defendants reportedly overstated the value of the acquired entity and promoted revenue and Adjusted EBITDA targets that lacked a reasonable basis in fact. The suit claims the acquisition was primarily motivated by the desire to generate fees for Resolute Holdings and individual defendants, rather than to provide long-term value to shareholders.
GPGI Investors Face September Deadline in Securities Fraud Lawsuit
Investors who purchased Class A common stock of GPGI, Inc., formerly known as CompoSecure, Inc., between November 3, 2025, and May 6, 2026, have until September 14, 2026, to seek appointment as lead plaintiff in a pending securities class action lawsuit filed against the company.

Investors who incurred losses may be eligible for compensation through a contingency fee arrangement. Those interested in serving as lead plaintiff must file a motion with the court by the September deadline. While Rosen Law Firm is actively soliciting participants, investors are not required to retain any specific counsel to remain members of the potential class, nor is serving as lead plaintiff a prerequisite for sharing in a future recovery.




Comments (0)
No comments yet. Be the first!